| abstract |
Compounds have high monoamine transport affinity and are characterized by one of the following two general formulas set out below in which the variables are as defined in the claims. The compounds bind selectively or non-selectively to monoamine transporters. The compounds are useful to treat various medical indications including, without limitation, attention deficit hyperactivity disorder (ADHD), Parkinson's disease, cocaine addiction, smoking cessation, weight reduction, obsessive-compulsive disorder, various forms of depression, traumatic brain injury, stroke, and narcolepsy. |